查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873996

生物技術市場

Biotechnology Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024 年生物技術市場價值約為 4,271.7 億美元，預計到 2031 年將達到 9,666.8 億美元，在此期間的年複合成長率(CAGR) 為 12.6%。

生物技術廣泛應用於工業生物加工、生物資訊學、食品與農業、醫療保健、自然資源管理和環境保護等許多領域。現代生物技術透過促進先進產品和技術的研發，推動創新，致力於攻克罕見疾病和疑難雜症，同時透過減少環境影響和增強糧食安全，促進永續發展。

此外，生物技術有助於實現更清潔、更節能的工業製造流程。推動市場發展的關鍵因素包括基因組定序成本的下降、技術的快速進步以及來自公共和私營部門的大力支持。行業會議和研討會數量的增加表明，人們對該領域的興趣和投資正在不斷成長，這凸顯了可能影響未來持續成長的重要市場趨勢。

生物技術市場分析

基因組定序成本的大幅下降是推動臨床遺傳學發展的主要動力，它改變了罕見疾病的診斷和治療方式，並加速了精準醫療的普及。人類基因組定序的成本已從2007年的約100萬美元驟降至2014年的1,000美元，目前約為600美元。

基因組定序成本的大幅降低使得定序更加普及，成為生技市場的主要成長動力。此外，製藥和生物製藥公司對基因組技術的日益廣泛應用也進一步推動了市場成長，因為這些公司利用定序資料進行藥物研發、標靶治療和個人化治療策略。

生物技術市場概覽

資訊學和生物學領域的專家擴大利用先進的定序技術來產生更準確、更全面的基因組資料。近年來，DNA組裝軟體和染色體序列定位創新技術取得了顯著進步，從而增強了基因組研究能力。

為了促進這些新興技術的應用，多項策略措施已經啟動。例如，美國國家人類基因組研究所（NHGRI）於1989年啟動了基因組定序計劃，旨在掌握基因組學領域不斷發展的機會。同時，基因組技術計畫正積極推動下一代工具和儀器的研發，以促進快速、經濟高效的DNA定序、功能基因組學實驗和SNP基因分型。該計劃還有助於技術從研發者向最終用戶轉移，鼓勵學術界和產業界研究機構之間的多學科合作。

市場也經歷了產業參與者的創新浪潮。太平洋生物科學公司（Sequel）和牛津奈米孔技術公司（PromethION）等公司推出了最先進的下一代定序（NGS）平台。同時，羅氏GS FLX（454）、Illumina HiSeq 2000（Solexa）和AB SOLiD（Agencourt）等系統持續佔據市場主導地位。這些技術進步顯著提高了基因組定序的速度、準確性和經濟性。

因此，定序技術的不斷創新預計將成為預測期內生物技術市場快速成長的關鍵驅動力。

全球生物技術市場按地區分類為北美、歐洲、亞太、中東和非洲以及南美和中美洲。北美，尤其是美國，是最大的生物技術市場。該地區的成長特點是：對生物製藥和生物技術公司創新產品的需求不斷成長，主要市場參與者的存在，以及許多學術和研究機構投入的大量研發資源。此外，持續的技術進步預計將進​​一步刺激北美市場的成長。

戰略洞察

生物技術市場促進因素與機遇

醫療保健領域對先進方法的日益重視將惠及美國市場

北美生技市場正經歷快速成長，這主要得益於先進技術在醫療保健領域的整合、對精準醫療日益成長的關注，以及公共和私營部門對基因組研究的大量投資。該地區已成為生物技術創新中心，這得益於旨在變革醫療服務模式、提高農業生產力和提升工業生物製造能力的合作努力。精準醫療是當代醫療保健領域最具變革性的趨勢之一，在美國和加拿大正獲得顯著發展。政府支持的各項舉措，以及創投和機構資金，正在推動基因組學、標靶治療和個人化診斷的研究。這種高度重視正在重塑臨床實踐，並為療效更佳、副作用更少的客製化治療方案鋪平道路。

由於研究項目的不斷發展和商業模式的調整，醫療和農業生物技術都取得了顯著進展。 CRISPR、合成生物學和分子診斷等生物工程工具正被用於創造新型生物分子、增強作物抗病性以及開發新一代治療產品。值得注意的是，2022年，美國衛生與公眾服務部（HHS）撥款4000萬美元，用於加強活性藥物成分（API）、抗生素以及生產關鍵藥物和提升疫情應對能力所需的重要原料的生物製造能力。這項投資旨在解決關鍵供應鏈的脆弱性，並支持藥品生產回流國內。同時，美國國防部（DoD）啟動了「三軍生物技術輔助韌性供應鏈」計劃，該計劃將在五年內獲得超過2.7億美元的資金支持。這項雄心勃勃的計畫旨在透過開發永續燃料、高性能材料、聚合物、樹脂和防護裝備等對國家安全和韌性至關重要的要素，加速生物基創新成果的商業化，尤其是在國防領域。

這些發展得益於波士頓、舊金山和多倫多等城市中生物技術公司、學術機構和創新集群的蓬勃發展。強大的智慧財產權框架、先進的研究基礎設施和高素質的勞動力也提升了該地區的全球競爭力。總而言之，在戰略投資、前沿創新和旨在增強醫療保健和產業韌性的政府舉措的推動下，北美生物技術市場有望實現持續成長。預計在預測期內，這種充滿活力的環境將釋放巨大的經濟價值，並鞏固該地區在全球生物技術領域的領先地位。

政府措施—生物技術市場的機遇

2023 年 12 月，生物技術部 (DBT) 和生物技術產業研究援助委員會 (BIRAC) 在新德里 Pragati Maidan 的 Bharat Mandapam 舉辦的第三屆全球生物印度展 (Global Bio-India) 上宣布推出 14 種由新創公司和企業家工業開發的新型生物技術產品，涵蓋醫療保健、診斷、醫療保健、農業保健、診斷、醫療保健和企業家工業開發的新型生物技術產品，涵蓋醫療保健、診斷、醫療、農業保健全球生物印度展是重要的國際生物技術盛會。

近年來這些進展有望為生物技術市場創造有吸引力的成長機會。

生物技術市場報告細分分析

生物技術市場分析的關鍵組成部分包括產品和應用。

依產品分類，生物技術市場可分為DNA定序、發酵、細胞分析、奈米生物技術、色譜法、PCR技術、組織工程與再生等技術。 2023年，DNA定序佔據最大的市場佔有率，預計在預測期內將保持最高的成長速度。 DNA定序是確定DNA鏈中核苷酸鹼基確切順序的關鍵技術。它已成為基礎研究和應用研究的必備工具，並在醫療保健、生物技術、農業和法醫學等領域有著廣泛的應用。

DNA定序技術最早的大規模應用之一是人類基因組計劃，該計劃歷時十三年，大大增進了我們對與遺傳疾病相關的基因突變的理解。如今，DNA定序技術使研究人員能夠識別與遺傳疾病相關的特定基因，有助於開發標靶療法和個人化醫療。

除了醫療保健領域，DNA定序也廣泛應用於親子鑑定和親緣關係分析等基因檢測。它在法醫學中也發揮著至關重要的作用，有助於識別犯罪嫌疑人和受害者。在環境領域，DNA定序有助於分析造成空氣、水和食物污染的細菌和其他微生物。

此外，這項技術在農業研究中至關重要，它使科學家能夠研究動植物物種的遺傳變異和遷移模式。這些資訊對於識別稀有品種以及最佳化種子和牲畜培育至關重要。

整體而言，DNA定序的多功能性和影響力持續推動著各領域的創新和投資。

包括賽默飛世爾科技公司、默克集團、Illumina公司以及眾多新創公司在內的多家公司，提供用於DNA定序技術的各種試劑盒和試劑。因此，DNA定序及其應用帶來的許多益處預計將在預測期內顯著推動該領域的成長。

依應用領域分類，生物技術市場可分為工業加工、生物資訊學、食品與農業、健康、自然資源與環境等應用。 2023年，工業加工領域佔據最大的市場佔有率，而生物資訊領域預計在預測期內將以更快的速度成長。工業加工或生物加工市場是生物技術領域最具發展前景的領域之一，對醫療保健和農業生物技術產生了重大影響，並為污染防治和資源保​​護提供了一種新方法。工業加工或生物加工市場能夠降低企業成本，創造新市場，同時最大限度地減少對環境的破壞。大多數的生物技術實驗室研究都是為了商業應用而進行。這些應用被用於藥物發現和開發。人類蛋白質的治療藥物是透過重組方法開發的。例如，重組人類胰島素是基因泰克公司於1982年生產和銷售的首個重組藥物。糖尿病盛行率的上升為重組胰島素帶來了豐厚的利潤，並推動了生物技術市場未來的顯著成長。此外，工業加工應用包括生產酵素和微生物，以在化學品、食品配料、洗滌劑、紙張、紡織品、飲料、織物、塑膠、個人護理、生物燃料等行業中創造生物基產品。

按地域分類的生物技術市場佔有率分析

生物技術市場報告的地理範圍主要分為五個區域：北美、亞太、歐洲、中東和非洲以及南美和中美洲。

亞太地區被公認為全球生技市場成長最快的地區。預計該地區的市場，尤其是中國、日本和印度等國家，將經歷顯著成長。這一成長歸功於市場參與者對發展中經濟體日益成長的關注以及政府的支持性政策。

生物技術市場報告範圍

生物技術市場新聞及最新動態

生物技術市場評估是透過收集定性和定量資料，結合一手和二手研究方法進行的，其中包括重要的企業出版物、協會資料和資料庫。以下列出了生物技術市場的最新發展和策略：

  • 2022年4月，CytoTronics獲得925萬美元的種子輪融資，由Anzu Partners領投，Milad Alucozai（BoxOne Ventures）及其他機構投資者參與。該公司利用這筆種子輪融資來推進其創新平台的發展，該平台採用電腦晶片技術進行基於細胞的電學和電化學分析。 （資料來源：CytoTronics，新聞稿，2022）

生物技術市場報告涵蓋範圍和成果

《生物技術市場規模及預測（2022-2030）》報告對市場進行了全面分析，涵蓋以下領域：

  • 涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測
  • 市場動態，例如促進因素、限制因素和關鍵機會
  • 未來主要趨勢
  • 詳細的PEST/波特五力模型與SWOT分析
  • 全球及區域市場分析，涵蓋關鍵市場趨勢、主要參與者、法規及近期市場發展動態。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 公司詳細概況

目錄

第1章：引言

第2章：全球生物技術市場－主要結論

第3章：全球生技市場－市場概況

  • 概述
  • 市場區隔
    • 全球生物技術市場—依技術分類
    • 全球生技市場－按應用領域分類
    • 全球生物技術市場－按地域分類
  • 害蟲分析
    • 北美 - PEST 分析
    • 歐洲 - PEST 分析
    • 亞太地區 - PEST 分析
    • 中東和非洲 - PEST 分析
    • 南美洲和中美洲—PEST分析

第4章：全球生技市場－主要市場動態

  • 關鍵市場促進因素
    • 基因組定序價格下降
    • 增加創新技術
    • 私營和政府機構的舉措日益增多
  • 主要市場限制因素
    • 與基因數據相關的風險
    • 基因改造作物的系統性風險
  • 主要市場機遇
    • NSG在生物標記發現與精準醫學的應用
  • 未來趨勢
    • 未來崛起會議與研討會
  • 影響分析

第5章：生技市場－全球分析

  • 全球生物技術市場收入預測與分析
  • 全球生技市場（依地域分類）－預測與分析
  • 市場定位
  • 關鍵球員表現
    • 賽默飛世爾科技公司 5.4.2 丹納赫
  • 專家意見

第6章：全球生物技術市場分析－依技術分類

  • 概述
  • DNA定序市場
  • 發酵市場
  • 細胞檢測市場
  • 奈米生物技術市場
  • 色譜市場
  • PCR技術市場
  • 組織工程與再生市場
  • 其他市場

第7章：全球生物技術市場分析－按應用領域分類

  • 概述
  • 工業/生物加工市場
  • 生物資訊市場
  • 食品和農業市場
  • 健康市場
  • 自然資源與環境市場
  • 其他市場

第8章：北美生技市場營收及至2025年的預測

  • 概述
  • 北美生物技術市場收入及至2025年預測
  • 北美生物技術市場收入及預測（按技術分類）
  • 北美生物技術市場收入及預測（按應用領域分類）
  • 北美生物技術市場收入及至2025年預測（按國家/地區分類）(%)
  • 美國生物技術市場收入及至2025年預測
    • 美國生物技術市場收入及至2025年預測
    • 美國生物技術市場收入及至2025年預測（依技術分類）
    • 美國生物技術市場收入及至2025年預測（按應用領域分類）
  • 加拿大生物技術市場收入及至2025年的預測
    • 加拿大生物技術市場收入及至2025年預測
    • 加拿大生物技術市場收入及至2025年預測（依技術分類）
    • 加拿大生物技術市場收入及至2025年預測（依應用領域分類）
  • 墨西哥生物技術市場收入及至2025年預測
    • 墨西哥生物技術市場收入及至2025年預測
    • 墨西哥生物技術市場收入及至2025年預測（依技術分類）
    • 墨西哥生物技術市場收入及至2025年預測（按應用領域分類）

第9章：歐洲生技市場收入及至2025年的預測

  • 概述
  • 歐洲生物技術市場收入及至2025年預測
  • 歐洲生物技術市場收入及預測（依技術分類）
  • 歐洲生物技術市場收入及預測（按應用領域分類）
  • 歐洲生物技術市場收入及至2025年預測（按國家/地區分類）(%)
  • 英國生物技術市場收入及至2025年預測
    • 英國生物技術市場收入及至2025年預測
    • 英國生物技術市場收入及至2025年預測（依技術分類）
    • 英國生物技術市場收入及至2025年預測（按應用領域分類）
  • 德國生物技術市場收入及至2025年的預測
    • 德國生物技術市場收入及至2025年預測
    • 德國生物技術市場收入及至2025年預測（依技術分類）
    • 德國生物技術市場收入及至2025年預測（依應用領域分類）
  • 法國生物技術市場收入及至2025年預測
    • 法國生物技術市場收入及至2025年預測
    • 法國生物技術市場收入及至2025年預測（依技術分類）
    • 法國生物技術市場收入及至2025年預測（依應用領域分類）

第0章：亞太生物技術市場收入及至2025年預測

  • 概述
  • 亞太生物技術市場收入及至2025年預測
  • 亞太生物技術市場收入及預測（依技術分類）
  • 亞太生物技術市場收入及預測（按應用領域分類）
  • 亞太地區生物技術市場收入及至2025年預測（按國家/地區分類）(%)
  • 中國生物技術市場收入及至2025年預測
    • 中國生物技術市場收入及至2025年預測
    • 中國生物技術市場收入及至2025年預測（依技術分類）
    • 中國生物技術市場收入及至2025年預測（依應用領域分類）
  • 日本生物技術市場收入及至2025年預測
    • 日本生物技術市場收入及至2025年預測
    • 日本生物技術市場收入及至2025年預測（依技術分類）
    • 日本生物技術市場收入及至2025年預測（依應用領域分類）
  • 印度生物技術市場收入及至2025年預測
    • 印度生物技術市場收入及至2025年預測
    • 印度生物技術市場收入及至2025年預測（依技術分類）
    • 印度生物技術市場收入及至2025年預測（按應用領域分類）

第11章：中東和非洲生物技術市場收入及至2025年預測

  • 概述
  • 中東及非洲生物技術市場收入及至2025年預測
  • 中東和非洲生物技術市場收入及預測（按技術分類）
  • 中東和非洲生物技術市場收入及預測（按應用領域分類）
  • 中東和非洲生物技術市場收入及至2025年預測（按國家/地區分類）
  • 阿拉伯聯合大公國生物技術市場營收及至2025年預測
  • 阿拉伯聯合大公國生物技術市場營收及至2025年預測
    • 阿拉伯聯合大公國生物技術市場收入及至2025年預測（依技術分類）
    • 阿拉伯聯合大公國生物技術市場收入及至2025年預測（依應用領域分類）
  • 沙烏地阿拉伯生物技術市場收入及至2025年預測
  • 沙烏地阿拉伯生物技術市場收入及至2025年預測
    • 沙烏地阿拉伯生物技術市場收入及至2025年預測（依技術分類）
    • 沙烏地阿拉伯生物技術市場收入及至2025年預測（按應用領域分類）
  • 南非生物技術市場收入及至2025年預測
  • 南非生物技術市場收入及至2025年預測
    • 南非生物技術市場收入及至2025年預測（依技術分類）
    • 南非生物技術市場收入及至2025年預測（依應用領域分類）

第12章：南美洲和中美洲生物技術市場收入及至2025年的預測

  • 概述
  • 南美洲和中美洲生物技術市場收入及至2025年的預測
  • 南美洲和中美洲生物技術市場收入及預測（按技術分類）
  • 南美洲和中美洲生物技術市場收入及預測（按應用領域分類）
  • 南美洲和中美洲生物技術市場收入及至2025年預測（按國家/地區分類，百分比）
  • 巴西生物技術市場收入及至2025年預測
    • 巴西生物技術市場收入及至2025年預測
    • 巴西生物技術市場收入及至2025年預測（依技術分類）
    • 巴西生物技術市場收入及至2025年預測（依應用領域分類）

第13章：生技市場－產業概況

  • 概述
  • 2016-2018年生物技術市場成長策略
  • 有機發展
    • 概述
  • 2016-2018年生物技術市場的有機成長策略
  • 產品發布
    • 生物技術市場參與者近期推出的產品
  • 產品認證
    • 生物技術市場參與者近期獲得的產品批准
  • 擴充
    • 生物技術市場，依擴張區分
  • 無機發展
    • 概述
  • 2016-2018年生物技術市場無機成長策略
  • 合作夥伴關係
    • 生物技術市場參與者近期建立的合作關係
  • 協定
    • 生物技術市場（按協議分類）
  • 併購
    • 生物技術市場參與者近期併購活動

第14章：生技市場－主要公司簡介

  • THERMO FISHER SCIENTIFIC INC.14.1.1 Key Facts
  • MERCK KGAA
  • PERKIN ELMER, INC.14.3.1 Key Facts
  • AGILENT TECHNOLOGIES, INC.14.4.1 Key Facts
  • F.HOFFMANN-LA ROCHE LTD.14.5.1 Key Facts
  • DANAHER
  • QIAGEN
  • BD
  • BIO-RAD LABORATORIES, INC.14.9.1 Key Facts
  • ILLUMINA, INC.14.10.1 Key Facts

第15章：附錄

簡介目錄
Product Code: TIPHE100001316

The Biotechnology Market was valued at approximately US$ 427.17 billion in 2024 and is projected to reach US$ 966.68 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.6% during this period.

Biotechnology is utilized in various fields, including industrial bioprocessing, bioinformatics, food and agriculture, healthcare, natural resource management, and environmental conservation. Modern biotechnology fosters innovation by facilitating the creation of advanced products and technologies aimed at tackling rare and complex diseases, while also promoting sustainability through reduced environmental impact and enhanced food security.

Moreover, biotechnology contributes to cleaner and more energy-efficient industrial manufacturing processes. Key factors driving the market include the decreasing costs of genome sequencing, rapid technological advancements, and robust support from both private and public sector initiatives. The increasing number of industry conferences and workshops indicates a growing interest and investment in the sector, highlighting important market trends that are likely to influence ongoing growth.

Biotechnology Market Analysis

The significant drop in genome sequencing costs has been a major driver in the advancement of clinical genetics, transforming the diagnosis and treatment of rare diseases and accelerating the adoption of precision medicine. The cost of sequencing a human genome has plummeted from around $1 million in 2007 to $1,000 in 2014, and it currently stands at approximately $600.

This dramatic reduction has made genome sequencing more accessible, serving as a primary growth driver in the biotechnology market. Additionally, the increasing use of genomic technologies by pharmaceutical and biopharmaceutical companies is further propelling market growth, as these companies utilize sequencing data for drug discovery, targeted therapies, and personalized treatment strategies.

Biotechnology Market Overview

Experts in informatics and biology are increasingly employing advanced sequencing technologies to produce more accurate and comprehensive genomic data. Recent years have witnessed significant advancements in software for DNA assembly and innovative techniques for locating sequences on chromosomes, thereby enhancing genomic research capabilities.

To promote the adoption of these emerging technologies, several strategic initiatives have been launched. For instance, the National Human Genome Research Institute (NHGRI) initiated the Genome Sequencing Program in 1989 to capitalize on evolving opportunities in genomics. Concurrently, the Genome Technology Program is actively fostering the development of next-generation tools and instruments that facilitate rapid, cost-effective DNA sequencing, functional genomics experiments, and SNP genotyping. This program also aids in technology transfer from developers to end-users, encouraging multidisciplinary collaboration between academic and industrial research settings.

The market has also experienced a surge in innovation from industry players. Companies such as Pacific Biosciences (Sequel) and Oxford Nanopore Technologies (PromethION) have launched state-of-the-art next-generation sequencing (NGS) platforms. Meanwhile, systems like Roche GS FLX (454), Illumina HiSeq 2000 (Solexa), and AB SOLiD (Agencourt) continue to dominate the market. These technological advancements have significantly enhanced the speed, accuracy, and affordability of genome sequencing.

Consequently, ongoing innovations in sequencing technologies are anticipated to be a key driver of rapid growth in the biotechnology market throughout the forecast period.

The global biotechnology market is categorized by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America, particularly the US, represents the largest biotechnology market. Growth in this region is characterized by an increasing demand for innovative products from biopharmaceutical and biotechnology companies, the presence of major market players, and extensive R&D efforts by various academic and research institutions. Furthermore, continuous technological advancements are expected to further stimulate market growth in North America.

Strategic Insights

Biotechnology Market Drivers and Opportunities

Growing Emphasis on Advanced Methods in Healthcare to Benefit the U.S. Market

The biotechnology market in North America is experiencing rapid growth, driven by the integration of advanced technologies in healthcare, an increasing focus on precision medicine, and significant investments in genomic research from both public and private sectors. The region has become a center for biotechnological innovation, supported by collaborative efforts aimed at transforming healthcare delivery, enhancing agricultural productivity, and improving industrial biomanufacturing capabilities. Precision medicine, one of the most transformative trends in contemporary healthcare, is gaining substantial traction in the U.S. and Canada. Government-backed initiatives, along with venture capital and institutional funding, are propelling research into genomics, targeted therapies, and personalized diagnostics. This heightened focus is reshaping clinical practices and paving the way for tailored treatment regimens that offer improved efficacy and reduced side effects.

Both medical and agricultural biotechnology have seen significant advancements due to evolving research programs and adaptive business models. Bioengineering tools such as CRISPR, synthetic biology, and molecular diagnostics are being employed to create novel biomolecules, enhance disease resistance in crops, and develop next-generation therapeutic products. Notably, in 2022, the U.S. Department of Health and Human Services (HHS) allocated US$40 million to bolster biomanufacturing capacity for active pharmaceutical ingredients (APIs), antibiotics, and essential raw materials needed for producing critical medicines and enhancing pandemic preparedness. This investment addresses vital supply chain vulnerabilities and supports the onshoring of pharmaceutical production. Simultaneously, the U.S. Department of Defense (DoD) initiated the Tri-Service Biotechnology for a Resilient Supply Chain program, backed by over US$270 million over five years. This ambitious initiative aims to accelerate the commercialization of bio-based innovations, particularly in the defense sector, by developing sustainable fuels, high-performance materials, polymers, resins, and protective gear-elements crucial to national security and resilience.

These developments are further bolstered by a growing ecosystem of biotech companies, academic institutions, and innovation clusters in cities like Boston, San Francisco, and Toronto. Strong intellectual property frameworks, advanced research infrastructure, and a skilled workforce are also enhancing the region's global competitiveness. In summary, North America's biotechnology market is poised for sustained growth, driven by strategic investments, cutting-edge innovation, and government initiatives aimed at strengthening both healthcare and industrial resilience. This dynamic environment is expected to unlock significant economic value and solidify the region's leadership in the global biotechnology landscape over the forecast period.

Government Initiatives - An Opportunity for the Biotechnology Market

In December 2023, the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) announced the introduction of 14 new biotech-based products developed by start-ups and entrepreneurs across various sectors, including healthcare, diagnostics, medical devices, agriculture, and industrial biotechnology, during the 3rd edition of Global Bio-India, a major international biotechnology event held at Bharat Mandapam, Pragati Maidan in New Delhi.

Such advancements in recent years are likely to create attractive growth opportunities for the biotechnology market.

Biotechnology Market Report Segmentation Analysis

Key segments contributing to the Biotechnology Market analysis include product and application.

By product, the biotechnology market is divided into DNA sequencing, fermentation, cell-based assays, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, and other technologies. The DNA sequencing segment held the largest market share in 2023 and is expected to grow at the highest rate during the forecast period. DNA sequencing is a vital technique for determining the exact order of nucleotide bases within a DNA strand. It has become essential in both basic and applied research, with extensive applications in healthcare, biotechnology, agriculture, and forensic science.

One of the earliest large-scale applications of DNA sequencing was in the Human Genome Project, which lasted thirteen years and significantly advanced our understanding of genetic mutations associated with hereditary diseases. Today, DNA sequencing allows researchers to identify specific genes linked to genetic disorders, aiding in the development of targeted therapies and personalized medicine.

Beyond healthcare, DNA sequencing is widely utilized in genetic testing for paternity and familial relationships. It also plays a crucial role in forensic science, assisting in the identification of crime suspects and victims. In environmental contexts, DNA sequencing helps analyze bacteria and other microorganisms that contribute to air, water, and food contamination.

Additionally, this technology is vital in agricultural research, enabling scientists to study genetic variation and migratory patterns among animal and plant species. This information is essential for identifying rare breeds and optimizing seed and livestock development.

Overall, the versatility and impact of DNA sequencing continue to drive innovation and investment across various sectors.

Numerous companies, including Thermo Fisher Scientific Inc., Merck KGaA, Illumina, Inc., and various start-ups, provide a range of kits and reagents for DNA sequencing techniques. Thus, the benefits offered by DNA sequencing and its applications are expected to significantly boost the growth of this segment in the forecast period.

By application, the biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, and other applications. The industrial processing segment held the largest market share in 2023, while the bioinformatics segment is anticipated to grow at a faster rate during the forecast period. The industrial processing or bioprocessing market is one of the most promising areas of biotechnology, significantly impacting healthcare and agricultural biotechnology, and offering a new approach to pollution prevention and resource conservation. The industrial processing or bioprocessing market provides businesses with lower costs and creates new markets while minimizing environmental disruption. Most laboratory studies in biotechnology are conducted for commercial applications. These applications are utilized for drug discovery and development. Therapeutics for human proteins are developed through recombinant methods. For example, recombinant human insulin was the first recombinant medicine produced and marketed by Genentech in 1982. The rising prevalence of diabetes has led to substantial profits for recombinant insulin, contributing to significant future growth in the biotechnology market. Furthermore, industrial processing applications include the production of enzymes and microorganisms to create bio-based products in sectors such as chemicals, food ingredients, detergents, paper, textiles, beverages, fabrics, plastics, personal care, biofuels, and more.

Biotechnology Market Share Analysis by Geography

The geographic scope of the Biotechnology Market report is primarily divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America.

Asia Pacific is recognized as the fastest-growing region in the global biotechnology market. The market in this region is expected to experience significant growth in countries such as China, Japan, and India. This growth is attributed to the increasing focus of market players in developing economies and supportive government policies.

Biotechnology Market Report Scope

Biotechnology Market News and Recent Developments

The Biotechnology Market is assessed by collecting qualitative and quantitative data through primary and secondary research, which includes important corporate publications, association data, and databases. Below is a list of recent developments in the biotechnology market and strategies:

  • In April 2022, CytoTronics secured US$9.25M in initial seed funding, led by Anzu Partners, in collaboration with Milad Alucozai (BoxOne Ventures) and institutional investors. The company utilized this seed funding to advance its innovative platform that employs computer chip technology for conducting electrical and electrochemical cell-based assays (Source: CytoTronics, Press Release, 2022)

Biotechnology Market Report Coverage and Deliverables

The "Biotechnology Market Size and Forecast (2022-2030)" report offers a comprehensive analysis of the market covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1.INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2.GLOBAL BIOTECHNOLOGY MARKET - KEY TAKEAWAYS

3.GLOBAL BIOTECHNOLOGY MARKET - MARKET LANDSCAPE

  • 3.1 OVERVIEW
  • 3.2 MARKET SEGMENTATION
    • 3.2.1 Global Biotechnology market - By Technology
    • 3.2.2 Global Biotechnology market - By Application
    • 3.2.3 Global Biotechnology market - By Geography
  • 3.3 PEST ANALYSIS
    • 3.3.1 North America - PEST Analysis
    • 3.3.2 Europe - PEST Analysis
    • 3.3.3 Asia Pacific - PEST Analysis
    • 3.3.4 Middle East and Africa - PEST Analysis
    • 3.3.5 South and Central America - PEST Analysis

4.GLOBAL BIOTECHNOLOGY MARKET - KEY MARKET DYNAMICS

  • 4.1 KEY MARKET DRIVERS
    • 4.1.1 Declining Prices of Genome Sequencing
    • 4.1.2 Increasing Innovative Technologies
    • 4.1.3 Increasing Number Of Initiatives By Private and Government Bodies
  • 4.2 KEY MARKET RESTRAINTS
    • 4.2.1 Risks Associated With Genetic Data
    • 4.2.2 Systemic Risks Of Genetically Modified Crops
  • 4.3 KEY MARKET OPPORTUNITIES
    • 4.3.1 Usage of NSG in Biomarker Discovery and Precision Medicine
  • 4.4 FUTURE TRENDS
    • 4.4.1 Rising Future Conferences and Workshops
  • 4.5 IMPACT ANALYSIS

5.BIOTECHNOLOGY MARKET - GLOBAL ANALYSIS

  • 5.1 GLOBAL BIOTECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS
  • 5.2 GLOBAL BIOTECHNOLOGY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
  • 5.3 MARKET POSITIONING
  • 5.4 PERFORMANCE OF KEY PLAYERS
    • 5.4.1 Thermo Fisher Scientific, Inc.5.4.2 Danaher
  • 5.5 EXPERT OPINIONS

6.GLOBAL BIOTECHNOLOGY MARKET ANALYSIS - BY TECHNOLOGY

  • 6.1 OVERVIEW
  • 6.2 DNA SEQUENCING MARKET
    • 6.2.1 Overview
    • 6.2.2 Global DNA Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.3 FERMENTATION MARKET
    • 6.3.1 Overview
    • 6.3.2 Global Fermentation Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.4 CELL BASED ASSAY MARKET
    • 6.4.1 Overview
    • 6.4.2 Global Cell Based Assay Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.5 NANOBIOTECHNOLOGY MARKET
    • 6.5.1 Overview
    • 6.5.2 Global Nanobiotechnology Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.6 CHROMATOGRAPHY MARKET
    • 6.6.1 Overview
    • 6.6.2 Global Chromatography Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.7 PCR TECHNOLOGY MARKET
    • 6.7.1 Overview
    • 6.7.2 Global PCR Technology Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.8 TISSUE ENGINEERING AND REGENERATION MARKET
    • 6.8.1 Overview
    • 6.8.2 Global Tissue Engineering And Regeneration Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.9 OTHERS MARKET
    • 6.9.1 Overview
    • 6.9.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

7.GLOBAL BIOTECHNOLOGY MARKET ANALYSIS - BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 INDUSTRIAL/BIO PROCESSING MARKET
    • 7.2.1 Overview
    • 7.2.2 Global Industrial/Bio Processing Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.3 BIOINFORMATICS MARKET
    • 7.3.1 Overview
    • 7.3.2 Global Bioinformatics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.4 FOOD & AGRICULTURE MARKET
    • 7.4.1 Overview
    • 7.4.2 Global Food & Agriculture Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.5 HEALTH MARKET
    • 7.5.1 Overview
    • 7.5.2 Global Health Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.6 NATURAL RESOURCE & ENVIRONMENT MARKET
    • 7.6.1 Overview
    • 7.6.2 Global Natural Resource & Environment Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.7 OTHERS MARKET
    • 7.7.1 Overview
    • 7.7.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

8.NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 8.3 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 8.4 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 8.5 NORTH AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 8.6 US BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.6.1 US Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.6.2 US Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.6.3 US Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 8.7 CANADA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.7.1 Canada Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.7.2 Canada Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.7.3 Canada Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 8.8 MEXICO BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 8.8.1 Mexico Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 8.8.2 Mexico Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 8.8.3 Mexico Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 9.1 OVERVIEW
  • 9.2 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 9.3 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 9.4 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 9.5 EUROPE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 9.6 UK BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.6.1 UK Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.6.2 UK Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.6.3 UK Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.7 GERMANY BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.7.1 Germany Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.7.2 Germany Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.7.3 Germany Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.8 FRANCE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.8.1 France Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.8.2 France Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 9.8.3 France Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

0.ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 0.1 OVERVIEW
  • 0.2 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 0.3 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 0.4 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 0.5 ASIA PACIFIC BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 0.6 CHINA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.6.1 China Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.6.2 China Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.6.3 China Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 0.7 JAPAN BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.7.1 Japan Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.7.2 Japan Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.7.3 Japan Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 0.8 INDIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 0.8.1 India Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 0.8.2 India Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 0.8.3 India Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11.MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 11.1 OVERVIEW
  • 11.2 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.3 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 11.4 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 11.5 MIDDLE EAST AND AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
  • 11.6 UAE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.7 UAE BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.7.1 UAE Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.7.2 UAE Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 11.8 SAUDI ARABIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.9 SAUDI ARABIA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.9.1 Saudi Arabia Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.9.2 Saudi Arabia Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 11.10 SOUTH AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 11.11 SOUTH AFRICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 11.11.1 South Africa Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 11.11.2 South Africa Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12.SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025

  • 12.1 OVERVIEW
  • 12.2 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 12.3 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN)
  • 12.4 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN)
  • 12.5 SOUTH AND CENTRAL AMERICA BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 12.6 BRAZIL BIOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 12.6.1 Brazil Biotechnology market Revenue and Forecasts to 2025 (US$ Mn)
    • 12.6.2 Brazil Biotechnology Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
    • 12.6.3 Brazil Biotechnology Market Revenue And Forecasts to 2025, By Application (US$ Mn)

13.BIOTECHNOLOGY MARKET - INDUSTRY LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.3 ORGANIC DEVELOPMENTS
    • 13.3.1 Overview
  • 13.4 ORGANIC GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.5 PRODUCT LAUNCHES
    • 13.5.1 Recent Product Launches By Players In The Biotechnology Market
  • 13.6 PRODUCT APPROVALS
    • 13.6.1 Recent Product Approvals By Players In The Biotechnology Market
  • 13.7 EXPANSIONS
    • 13.7.1 The Biotechnology Market, By Expansions
  • 13.8 INORGANIC DEVELOPMENTS
    • 13.8.1 Overview
  • 13.9 INORGANIC GROWTH STRATEGIES IN THE BIOTECHNOLOGY MARKET, 2016-2018
  • 13.10 PARTNERSHIPS
    • 13.10.1 Recent Partnerships by Players in the Biotechnology Market
  • 13.11 AGREEMENTS
    • 13.11.1 The Biotechnology Market, By Agreements
  • 13.12 MERGERS AND ACQUISITIONS
    • 13.12.1 Recent Mergers and Acquisitions By Players In The Biotechnology Market

14.BIOTECHNOLOGY MARKET - KEY COMPANY PROFILES

  • 14.1 THERMO FISHER SCIENTIFIC INC.14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Financial Overview
    • 14.1.4 Product Portfolio
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 MERCK KGAA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Financial Overview
    • 14.2.4 Product Portfolio
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 PERKIN ELMER, INC.14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Financial Overview
    • 14.3.4 Product Portfolio
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 AGILENT TECHNOLOGIES, INC.14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Financial Overview
    • 14.4.4 Product Portfolio
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 F.HOFFMANN-LA ROCHE LTD.14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Financial Overview
    • 14.5.4 Product Portfolio
    • 14.5.5 Swot Analysis
    • 14.5.6 Key Developments
  • 14.6 DANAHER
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Financial Overview
    • 14.6.4 Product Portfolio
    • 14.6.5 Swot Analysis
    • 14.6.6 Key Developments
  • 14.7 QIAGEN
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Financial Overview
    • 14.7.4 Product Portfolio
    • 14.7.5 Swot Analysis
    • 14.7.6 Key Developments
  • 14.8 BD
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Financial Overview
    • 14.8.4 Product Portfolio
    • 14.8.5 Swot Analysis
    • 14.8.6 Key Developments
  • 14.9 BIO-RAD LABORATORIES, INC.14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Financial Overview
    • 14.9.4 Product Portfolio
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 ILLUMINA, INC.14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Financial Overview
    • 14.10.4 Product Portfolio
    • 14.10.5 Swot Analysis
    • 14.10.6 Key Developments

15.APPENDIX

  • 15.1 ABOUT THE INSIGHT PARTNERS
  • 15.2 GLOSSARY OF TERMS
  • 15.3 METHODOLOGY
    • 15.3.1 Coverage
    • 15.3.2 Secondary Research
    • 15.3.3 Primary Research 185